#pharmaceutical companies in san diego
We are dedicated to the discovery, development, and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases.
Our current efforts focus on catecholamine-resistant hypotension, conditions characterized by iron overload, serious bacterial infections and rare genetic disorders.
Our researchers are focused on expanding our pipeline by developing innovative new therapies.
Welcome to La Jolla Pharmaceutical Company
We are a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. We have several product candidates in development that we believe have been significantly de-risked. LJPC-501 is our proprietary formulation of angiotensin II, a naturally occurring regulator of blood pressure. LJPC-401 is our novel formulation of hepcidin, an endogenous peptide hormone that controls and regulates iron metabolism. LJPC-30Sa and LJPC-30Sb are La Jolla’s purified derivatives of gentamicin, an FDA-approved antibiotic.
Recent News Corporate Presentation
© 2016 La Jolla Pharmaceutical Company